Toggle SGML Header (+)


Section 1: 10-Q (10-Q)

Document
false--02-23Q320182018-12-010001646972falseNon-accelerated Filerfalse14000000.010.01100000000010000000002796540282778820102796540282778820100.0870.07450.05690.06520.03950.04320.066250.05750.03606100000203000000.010.013000000030000000000001772018 0001646972 2018-02-25 2018-12-01 0001646972 2019-01-14 0001646972 2018-12-01 0001646972 2018-02-24 0001646972 2017-02-26 2017-12-02 0001646972 2018-09-09 2018-12-01 0001646972 2017-09-10 2017-12-02 0001646972 2017-12-02 0001646972 2017-02-25 0001646972 us-gaap:PhantomShareUnitsPSUsMember aci:TimeBasedVestingMember 2018-11-09 2018-11-09 0001646972 aci:PharmacyMember 2018-02-24 0001646972 srt:MaximumMember us-gaap:SubsequentEventMember 2018-12-17 2018-12-17 0001646972 srt:MinimumMember us-gaap:SubsequentEventMember 2018-12-17 2018-12-17 0001646972 us-gaap:AccountingStandardsUpdate201707Member 2018-09-09 2018-12-01 0001646972 2018-08-16 2018-08-16 0001646972 us-gaap:SubsequentEventMember 2018-12-17 2018-12-17 0001646972 us-gaap:AccountingStandardsUpdate201409Member us-gaap:RetainedEarningsMember 2018-02-25 0001646972 us-gaap:PhantomShareUnitsPSUsMember 2018-12-01 0001646972 us-gaap:PhantomShareUnitsPSUsMember 2018-11-09 2018-11-09 0001646972 us-gaap:CommonStockMember 2018-09-09 2018-12-01 0001646972 2017-12-03 2018-02-24 0001646972 us-gaap:PhantomShareUnitsPSUsMember aci:PerformanceBasedVestingMember 2018-11-09 2018-11-09 0001646972 us-gaap:AccountingStandardsUpdate201707Member 2018-02-25 2018-12-01 0001646972 us-gaap:PhantomShareUnitsPSUsMember 2018-02-25 2018-12-01 0001646972 us-gaap:AccountingStandardsUpdate201618Member 2017-02-26 2017-12-02 0001646972 aci:PharmacyMember 2018-12-01 0001646972 aci:NonPerishablesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-09-09 2018-12-01 0001646972 aci:NonPerishablesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-09-10 2017-12-02 0001646972 aci:PharmacyMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-02-25 2018-12-01 0001646972 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-02-25 2018-12-01 0001646972 aci:NonPerishablesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-02-25 2018-12-01 0001646972 aci:PerishablesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-02-26 2017-12-02 0001646972 us-gaap:FuelMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-09-10 2017-12-02 0001646972 aci:PharmacyMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-02-26 2017-12-02 0001646972 aci:PerishablesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-09-10 2017-12-02 0001646972 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-02-26 2017-12-02 0001646972 aci:OtherProductsandServicesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-09-10 2017-12-02 0001646972 aci:PerishablesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-09-09 2018-12-01 0001646972 us-gaap:FuelMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-02-25 2018-12-01 0001646972 aci:OtherProductsandServicesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-09-09 2018-12-01 0001646972 us-gaap:FuelMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-02-26 2017-12-02 0001646972 us-gaap:FuelMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-09-09 2018-12-01 0001646972 aci:NonPerishablesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-02-26 2017-12-02 0001646972 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-09-09 2018-12-01 0001646972 aci:PharmacyMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-09-10 2017-12-02 0001646972 aci:OtherProductsandServicesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-02-25 2018-12-01 0001646972 aci:PharmacyMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-09-09 2018-12-01 0001646972 aci:PerishablesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2018-02-25 2018-12-01 0001646972 us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-09-10 2017-12-02 0001646972 aci:OtherProductsandServicesMember us-gaap:SalesRevenueProductLineMember us-gaap:ProductConcentrationRiskMember 2017-02-26 2017-12-02 0001646972 aci:ContingentConsiderationMember 2018-02-24 0001646972 aci:ContingentConsiderationMember 2018-02-25 2018-12-01 0001646972 aci:ContingentConsiderationMember 2018-12-01 0001646972 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-12-01 0001646972 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-02-24 0001646972 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-12-01 0001646972 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-02-24 0001646972 us-gaap:FairValueMeasurementsRecurringMember 2018-02-24 0001646972 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-02-24 0001646972 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-02-24 0001646972 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-02-24 0001646972 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-02-24 0001646972 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-02-24 0001646972 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2018-02-24 0001646972 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-02-24 0001646972 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-01 0001646972 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-01 0001646972 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-01 0001646972 us-gaap:FairValueMeasurementsRecurringMember 2018-12-01 0001646972 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-01 0001646972 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-01 0001646972 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-01 0001646972 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-01 0001646972 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-02-26 2017-12-02 0001646972 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-02-25 2018-12-01 0001646972 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-09 2018-12-01 0001646972 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-09-10 2017-12-02 0001646972 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-01 0001646972 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-06-20 2018-06-20 0001646972 aci:InterestRateSwapOneMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-06-20 0001646972 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-02-24 0001646972 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-02-24 0001646972 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-01 0001646972 aci:InterestRateSwapTwoMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-06-20 0001646972 aci:AssetBasedLoanFacilityMember us-gaap:LineOfCreditMember 2018-02-24 0001646972 aci:SafewayNotesRepurchaseMember us-gaap:NotesPayableToBanksMember 2018-12-01 0001646972 aci:A2018TermB7LoanMaturity2025Member us-gaap:SecuredDebtMember 2018-11-16 2018-11-16 0001646972 aci:NewTermB4LoanMaturity2021Member us-gaap:SecuredDebtMember 2017-06-27 0001646972 aci:AssetBasedLoanFacilityMember us-gaap:LineOfCreditMember 2018-12-01 0001646972 aci:AssetBasedLoanFacilityMember us-gaap:LineOfCreditMember 2018-11-16 0001646972 aci:A2018TermB7LoanMaturity2025Member us-gaap:SecuredDebtMember 2018-11-16 0001646972 aci:A2018TermB7LoanMaturity2025Member us-gaap:SecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-11-16 2018-11-16 0001646972 aci:NewTermB4LoanMaturity2021Member us-gaap:SecuredDebtMember 2018-11-16 2018-11-16 0001646972 aci:NALPNotesRepurchaseMember us-gaap:NotesPayableToBanksMember 2018-12-01 0001646972 aci:NALPNotesRepurchaseMember us-gaap:NotesPayableToBanksMember 2018-09-09 2018-12-01 0001646972 aci:FloatRateNotesMember 2018-06-25 2018-06-25 0001646972 aci:LetterOfCreditSubFacilityMember 2018-12-01 0001646972 srt:MaximumMember 2018-12-01 0001646972 aci:SafewayNotesRepurchaseMember us-gaap:NotesPayableToBanksMember 2018-09-09 2018-12-01 0001646972 aci:LetterOfCreditSubFacilityMember 2018-02-24 0001646972 aci:AssetBasedLoanFacilityMember us-gaap:LineOfCreditMember 2018-11-16 2018-11-16 0001646972 aci:FloatRateNotesMember 2018-06-25 0001646972 aci:A2018TermB7LoanMaturity2025Member us-gaap:SecuredDebtMember us-gaap:BaseRateMember 2018-11-16 2018-11-16 0001646972 aci:FloatRateNotesMember us-gaap:DebtInstrumentRedemptionPeriodOneMember 2018-06-25 2018-06-25 0001646972 aci:NALPNotesMaturity2027To2031Member us-gaap:NotesPayableToBanksMember 2018-12-01 0001646972 aci:UnsecuredNotesPayableMember us-gaap:NotesPayableOtherPayablesMember 2018-12-01 0001646972 aci:SecuredMortgageNotesPayableMember us-gaap:MortgagesMember 2018-12-01 0001646972 aci:TermLoansMaturity2022to2025Member us-gaap:SecuredDebtMember 2018-02-24 0001646972 aci:SafewayNotesMaturity2019to2031Member us-gaap:NotesPayableToBanksMember 2018-02-24 0001646972 aci:TermLoansMaturity2022to2025Member us-gaap:SecuredDebtMember 2018-12-01 0001646972 aci:SeniorUnsecuredNotesMaturity2024and2025Member us-gaap:SeniorNotesMember 2018-02-24 0001646972 aci:SeniorUnsecuredNotesMaturity2024and2025Member us-gaap:SeniorNotesMember 2018-12-01 0001646972 aci:SafewayNotesMaturity2019to2031Member us-gaap:NotesPayableToBanksMember 2018-12-01 0001646972 aci:UnsecuredNotesPayableMember us-gaap:NotesPayableOtherPayablesMember 2018-02-24 0001646972 aci:SecuredMortgageNotesPayableMember us-gaap:MortgagesMember 2018-02-24 0001646972 aci:NALPNotesMaturity2027To2031Member us-gaap:NotesPayableToBanksMember 2018-02-24 0001646972 srt:MaximumMember aci:SafewayNotesMaturity2019to2031Member us-gaap:NotesPayableToBanksMember 2018-12-01 0001646972 srt:MaximumMember aci:NALPNotesMaturity2027To2031Member us-gaap:NotesPayableToBanksMember 2018-12-01 0001646972 srt:MinimumMember aci:SafewayNotesMaturity2019to2031Member us-gaap:NotesPayableToBanksMember 2018-12-01 0001646972 srt:MinimumMember aci:NALPNotesMaturity2027To2031Member us-gaap:NotesPayableToBanksMember 2018-12-01 0001646972 srt:MaximumMember aci:TermLoansMaturity2022to2025Member us-gaap:SecuredDebtMember 2018-12-01 0001646972 aci:SeniorUnsecuredNotesMaturity2025Member us-gaap:SeniorNotesMember 2018-12-01 0001646972 srt:MinimumMember aci:TermLoansMaturity2022to2025Member us-gaap:SecuredDebtMember 2018-12-01 0001646972 aci:SeniorUnsecuredNotesMaturity2024Member us-gaap:SeniorNotesMember 2018-12-01 0001646972 us-gaap:PensionPlansDefinedBenefitMember 2017-09-10 2017-12-02 0001646972 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-09-09 2018-12-01 0001646972 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-09-10 2017-12-02 0001646972 us-gaap:PensionPlansDefinedBenefitMember 2018-09-09 2018-12-01 0001646972 us-gaap:PensionPlansDefinedBenefitMember 2018-02-25 2018-12-01 0001646972 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-02-26 2017-12-02 0001646972 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-02-25 2018-12-01 0001646972 us-gaap:PensionPlansDefinedBenefitMember 2017-02-26 2017-12-02 0001646972 aci:BlackfeetTribeMember aci:ConsolidatedCasesForMultidistrictLitigationMember us-gaap:ThreatenedLitigationMember 2018-08-29 2018-08-29 0001646972 aci:QuiTamLawsuitsMember srt:MinimumMember us-gaap:PendingLitigationMember 2018-02-25 2018-12-01 0001646972 aci:SecurityBreachMember us-gaap:ThreatenedLitigationMember 2015-10-06 0001646972 aci:SafewayIncMember aci:Safeways401kPlanMember us-gaap:PendingLitigationMember 2018-12-01 0001646972 aci:SecurityBreachMember 2013-12-29 2015-01-03 0001646972 aci:QuiTamLawsuitsMember us-gaap:PendingLitigationMember 2018-12-01 0001646972 aci:ConsolidatedCasesForMultidistrictLitigationMember 2018-12-01 0001646972 aci:SecurityBreachMember 2015-01-03 0001646972 us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-02 0001646972 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-02-25 0001646972 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-02-25 0001646972 aci:AccumulatedOtherComprehensiveIncomeOtherAttributabletoParentMember 2017-02-26 2017-12-02 0001646972 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2017-02-26 2017-12-02 0001646972 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2017-12-02 0001646972 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-02-26 2017-12-02 0001646972 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2017-02-25 0001646972 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-02 0001646972 us-gaap:AccumulatedTranslationAdjustmentMember 2017-02-26 2017-12-02 0001646972 aci:AccumulatedOtherComprehensiveIncomeOtherAttributabletoParentMember 2017-02-25 0001646972 aci:AccumulatedOtherComprehensiveIncomeOtherAttributabletoParentMember 2017-12-02 0001646972 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-02 0001646972 us-gaap:AccumulatedTranslationAdjustmentMember 2017-02-25 0001646972 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-12-01 0001646972 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-01 0001646972 aci:AccumulatedOtherComprehensiveIncomeOtherAttributabletoParentMember 2018-02-25 2018-12-01 0001646972 us-gaap:AccumulatedTranslationAdjustmentMember 2018-02-24 0001646972 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-02-24 0001646972 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-02-25 2018-12-01 0001646972 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-02-25 2018-12-01 0001646972 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-01 0001646972 us-gaap:AccumulatedTranslationAdjustmentMember 2018-02-25 2018-12-01 0001646972 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-01 0001646972 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-02-24 0001646972 aci:AccumulatedOtherComprehensiveIncomeOtherAttributabletoParentMember 2018-02-24 0001646972 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-02-24 0001646972 aci:AccumulatedOtherComprehensiveIncomeOtherAttributabletoParentMember 2018-12-01 aci:division aci:incident aci:derivative iso4217:USD xbrli:shares aci:claim aci:property iso4217:USD xbrli:shares aci:store_format aci:segment xbrli:pure aci:store aci:lawsuit
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 1, 2018
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____ to _____
Commission File Number: 333-205546
396360519_abscompanieslogoa24.jpg
Albertsons Companies, Inc.
(Exact name of registrant as specified in its charter)
Delaware
 
47-4376911
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
 
250 Parkcenter Blvd.
 
 
Boise, Idaho
 
83706
(Address of principal
executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code (208) 395-6200
Not applicable
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes   No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   Yes   No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
¨
Accelerated filer
 
¨
 
 
 
 
Non-accelerated filer
 
x  (Do not check if a smaller reporting company)
Smaller reporting company
 
¨
 
 
 
 
 
 
Emerging Growth Company
 
o
 
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  ¨ Yes  x No
As of January 14, 2019, the registrant had 277,882,010 shares of common stock, par value $0.01 per share, outstanding.



Albertsons Companies, Inc. and Subsidiaries


 
 
 
 
 
 
 
 
Page
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 



Table of Contents
PART I - FINANCIAL INFORMATION
Item 1 - Condensed Consolidated Financial Statements (unaudited)

Albertsons Companies, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in millions, except share data)
(unaudited)



 
 
December 1,
2018
 
February 24,
2018
ASSETS
 
 
 
Current assets
 
 
 
 
Cash and cash equivalents
$
462.6

 
$
670.3

 
Receivables, net
566.9

 
615.3

 
Inventories, net
4,639.5

 
4,421.1

 
Other current assets
443.6

 
441.9

 
          Total current assets
6,112.6

 
6,148.6

 
 
 
 
 
Property and equipment, net
10,143.3

 
10,770.3

Intangible assets, net
2,893.3

 
3,142.5

Goodwill
1,183.3

 
1,183.3

Other assets
649.2

 
567.6

TOTAL ASSETS
$
20,981.7

 
$
21,812.3

 
 
 
 
 
LIABILITIES
 
 
 
Current liabilities
 
 
 
 
Accounts payable
$
3,119.2

 
$
2,833.0

 
Accrued salaries and wages
1,020.6

 
984.1

 
Current maturities of long-term debt and capitalized lease obligations
412.6

 
168.2

 
Other current liabilities
988.3

 
1,044.3

 
          Total current liabilities
5,540.7

 
5,029.6

 
 
 
 
 
Long-term debt and capitalized lease obligations
10,565.3

 
11,707.6

Deferred income taxes
595.0

 
579.9

Other long-term liabilities
2,890.6

 
3,097.0

 
 
 
 
Commitments and contingencies


 


 
 
 
 
STOCKHOLDERS' EQUITY
 
 
 
 
Preferred stock, $0.01 par value; 30,000,000 shares authorized, no shares issued and outstanding as of December 1, 2018 and February 24, 2018, respectively

 

 
Common stock, $0.01 par value; 1,000,000,000 shares authorized and 277,882,010 shares issued and outstanding as of December 1, 2018, and 1,000,000,000 shares authorized and 279,654,028 shares issued and outstanding as of February 24, 2018
2.8

 
2.8

 
Additional paid-in capital
1,788.7

 
1,773.3

 
Treasury stock, at cost, 1,772,018 and no shares held as of December 1, 2018 and February 24, 2018, respectively
(25.8
)
 

 
Accumulated other comprehensive income
192.1

 
191.1

 
Accumulated deficit
(567.7
)
 
(569.0
)
 
          Total stockholders' equity
1,390.1

 
1,398.2

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
$
20,981.7

 
$
21,812.3


The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.


3


Table of Contents


Albertsons Companies, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(in millions)
(unaudited)

 
12 weeks ended
 
40 weeks ended
 
December 1,
2018
 
December 2,
2017
 
December 1,
2018
 
December 2,
2017
Net sales and other revenue
$
13,840.4

 
$
13,599.2

 
$
46,517.9

 
$
45,890.9

Cost of sales
9,988.0

 
9,974.6

 
33,682.0

 
33,478.1

Gross profit
3,852.4

 
3,624.6

 
12,835.9

 
12,412.8

 
 
 
 
 
 
 
 
Selling and administrative expenses
3,678.0

 
3,725.7

 
12,337.0

 
12,509.0

Goodwill impairment

 

 

 
142.3

Operating income (loss)
174.4

 
(101.1
)
 
498.9

 
(238.5
)
 
 
 
 
 
 
 
 
Interest expense, net
213.0

 
193.9

 
662.5

 
679.2

Loss (gain) on debt extinguishment
9.5

 
(5.0
)
 
9.5

 
(5.0
)
Other (income) expense
(28.3
)
 
15.4

 
(88.3
)
 
20.1

Loss before income taxes
(19.8
)
 
(305.4
)
 
(84.8
)
 
(932.8
)
 
 
 
 
 
 
 
 
Income tax benefit
(65.4
)
 
(523.5
)
 
(80.3
)
 
(590.8
)
Net income (loss)
$
45.6

 
$
218.1

 
$
(4.5
)
 
$
(342.0
)
 
 
 
 
 
 
 
 
Other comprehensive income (loss), net of tax
 
 
 
 
 
 
 
Gain on interest rate swaps
0.9

 
22.2

 
4.3

 
22.6

Recognition of pension (loss) gain
(0.5
)
 
2.4

 
(1.6
)
 
6.0

Foreign currency translation adjustment
0.3

 
(11.6
)
 
(0.3
)
 
14.3

Other
(0.8
)
 
(7.8
)
 
(1.4
)
 
(3.6
)
Other comprehensive income (loss)
$
(0.1
)
 
$
5.2

 
1.0

 
39.3

 
 
 
 
 
 
 
 
Comprehensive income (loss)
$
45.5

 
$
223.3

 
$
(3.5
)
 
$
(302.7
)

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.


4


Table of Contents


Albertsons Companies, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(in millions)
(unaudited)


 
40 weeks ended
 
December 1,
2018

December 2,
2017
Cash flows from operating activities:
 
 
 
  Net loss
$
(4.5
)
 
$
(342.0
)
Adjustments to reconcile net loss to net cash provided by operating activities:
 
 
 
Net (gain) loss on property dispositions, asset impairment and lease exit costs
(163.7
)
 
66.8

Goodwill impairment

 
142.3

Depreciation and amortization
1,340.8

 
1,462.0

LIFO expense
15.7

 
24.0

Deferred income tax
(135.2
)
 
(629.7
)
Contributions to pension and post-retirement benefit plans, net of expense
(178.2
)
 
(0.9
)
Amortization and write-off of deferred financing costs
38.3

 
48.5

Loss (gain) on debt extinguishment
9.5

 
(5.0
)
Equity-based compensation expense
35.5

 
24.6

Other
(35.9
)
 
93.0

Changes in operating assets and liabilities, net of effects of acquisition of businesses:
 
 
 
Receivables, net
47.1

 
29.7

Inventories, net
(234.0
)
 
(278.9
)
Accounts payable, accrued salaries and wages and other accrued liabilities
347.4

 
159.6

Other operating assets and liabilities
(13.7
)
 
(83.4
)
Net cash provided by operating activities
1,069.1

 
710.6

 
 
 
 
Cash flows from investing activities:
 
 
 
Business acquisitions, net of cash acquired

 
(148.8
)
Payments for property, equipment and intangibles, including payments for lease buyouts
(916.9
)
 
(1,062.7
)
Proceeds from sale of assets
529.3

 
652.6

Other
27.0

 
(55.5
)
Net cash used in investing activities
(360.6
)
 
(614.4
)
 
 
 
 
Cash flows from financing activities:
 
 
 
Proceeds from issuance of long-term debt
1,365.8

 
290.0

Payments on long-term borrowings
(2,113.8
)
 
(830.6
)
Payments of obligations under capital leases
(74.5
)
 
(82.8
)
Payments for debt financing costs
(18.6
)
 
(1.5
)
Member distribution

 
(250.0
)
Purchase of treasury stock, at cost
(25.8
)
 

Proceeds from financing leases

 
99.9

Other
(36.3
)
 
(65.7
)
Net cash used in financing activities
(903.2
)
 
(840.7
)
 
 
 
 
Net decrease in cash and cash equivalents and restricted cash
(194.7
)
 
(744.5
)
Cash and cash equivalents and restricted cash at beginning of period
680.8

 
1,229.1

Cash and cash equivalents and restricted cash at end of period
$
486.1

 
$
484.6


The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

5


Table of Contents
Albertsons Companies, Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(unaudited)


NOTE 1 - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation

The accompanying interim Condensed Consolidated Financial Statements include the accounts of Albertsons Companies, Inc. and its subsidiaries (the "Company"). All significant intercompany balances and transactions were eliminated. The Condensed Consolidated Balance Sheet as of February 24, 2018 is derived from the Company's annual audited Consolidated Financial Statements for the fiscal year ended February 24, 2018, which should be read in conjunction with these Condensed Consolidated Financial Statements and which are included in the Company's Annual Report on Form 10-K. Certain information in footnote disclosures normally included in annual financial statements was condensed or omitted for the interim periods presented in accordance with accounting principles generally accepted in the United States of America ("GAAP"). In the opinion of management, the interim data includes all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. The interim results of operations and cash flows are not necessarily indicative of those results and cash flows expected for the year. The Company’s results of operations are for the 12 and 40 weeks ended December 1, 2018 and December 2, 2017.
Prior Period Reclassifications

Certain prior period amounts have been reclassified to conform to the current period presentation, including the addition of Restricted cash to Cash and cash equivalents on the Condensed Consolidated Statements of Cash Flows, and the reclassification of non-service cost components of Net pension and post-retirement expense to Other (income) expense from Selling and administrative expenses on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss), as a result of the adoption of new accounting guidance.
Significant Accounting Policies
Restricted cash: Restricted cash is included in Other current assets or Other assets depending on the remaining term of the restriction and primarily relates to funds held in escrow. The Company had $23.5 million and $10.5 million of Restricted cash as of December 1, 2018 and February 24, 2018, respectively.
Inventories, net: Substantially all of the Company’s inventories consist of finished goods valued at the lower of cost or market and net of vendor allowances. The Company uses either item-cost or the retail inventory method to value inventory at lower of cost or market before application of any last-in, first-out ("LIFO") reserve. Interim LIFO inventory costs are based on management's estimates of expected year-end inventory levels and inflation rates. The Company recorded LIFO expense of $2.8 million and $0.4 million for the 12 weeks ended December 1, 2018 and December 2, 2017, respectively and $15.7 million and $24.0 million for the 40 weeks ended December 1, 2018 and December 2, 2017, respectively.

Equity-based compensation: The Company maintains the Albertsons Companies, Inc. Phantom Unit Plan (the "Phantom Unit Plan"), an equity-based incentive plan, which provides for grants of Phantom Units to certain employees, directors and consultants. Each Phantom Unit provides the participant with a contractual right to receive, upon vesting, one management incentive unit in each of the Company's parents, Albertsons Investor Holdings LLC and KIM ACI, LLC, that collectively own all of the outstanding shares of the Company. The Phantom Units vest over a service period, or upon a combination of both a service period and achievement of certain performance-based thresholds. The fair value of the Phantom Units is determined using an option pricing model, adjusted for lack of marketability and using an expected term or time to liquidity based on judgments made by management. Equity-based compensation expense recognized by the Company related to these plans was $9.9 million and $6.5 million for the 12 weeks ended December 1, 2018 and December 2, 2017, respectively. For the 40 weeks ended December 1, 2018 and December 2, 2017, equity-based compensation expense was $35.5 million and $24.6 million, respectively. The Company recorded an income tax benefit of $2.7 million and $1.3 million related to equity-based compensation for the 12 weeks ended December 1,

6


Table of Contents

2018 and December 2, 2017, respectively. For the 40 weeks ended December 1, 2018 and December 2, 2017, the Company recorded an income tax benefit of $9.6 million and $5.0 million, respectively. On November 9, 2018, the Company issued 1,281,416 phantom units to employees, which includes 948,254 time-based vesting units that were deemed granted. The remaining 333,162 units will only be deemed granted upon the establishment of the annual performance target for fiscal 2019, fiscal 2020 and fiscal 2021, as applicable. The 948,254 units deemed granted have an aggregate grant date value of $30.3 million. As of December 1, 2018, there was $71.5 million of unrecognized costs related to 2.7 million unvested Phantom Units. That cost is expected to be recognized over a weighted average period of 2.2 years.

Treasury Stock: During the 12 weeks ended December 1, 2018, the Company repurchased 1,772,018 shares of common stock allocable to certain current and former members of management ("the management holders") for $25.8 million in cash. The shares are classified as treasury stock on the Condensed Consolidated Balance Sheet. The shares repurchased represented a portion of the shares allocable to management. Proceeds from the repurchase were used by the management holders to repay outstanding loans of the management holders with a third party financial institution. As there is no current active market for shares of the Company’s common stock, the shares were repurchased at a negotiated price between the Company and the management holders.

Income taxes: On December 22, 2017, the President signed the Tax Cuts and Jobs Act (the "Tax Act") into law, which enacted significant changes to U.S. income tax and related laws. Among other things, the Tax Act reduces the top U.S. corporate income tax rate from 35% to 21%, and makes changes to certain other business-related exclusions, deductions and credits. Also on December 22, 2017, the SEC staff issued Staff Accounting Bulletin No. 118 ("SAB 118") to address the application of GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed in reasonable detail to complete the accounting for income tax effects of the Tax Act. SAB 118 allows the Company to record provisional amounts during a measurement period not to extend beyond one year from the date of enactment. The Tax Act was effective in the fourth quarter of fiscal 2017, during which the Company recorded a provisional tax benefit of $430.4 million. The Company recorded additional provisional benefit of $60.3 million during the 40 weeks ended December 1, 2018, primarily to account for refinement of the transition tax, and the remeasurement of deferred taxes. As of December 1, 2018, the Company had not completed its accounting for the Tax Act. The Company continues to analyze the Tax Act and refine its calculations, which could impact the measurement of its tax balances. The Company expects to complete its analysis in the fourth quarter of fiscal 2018 in accordance with SAB 118.

Income tax benefit was $65.4 million and $523.5 million for the 12 weeks ended December 1, 2018 and December 2, 2017, respectively. Income tax benefit was $80.3 million and $590.8 million for the 40 weeks ended December 1, 2018 and December 2, 2017, respectively. The tax benefit in fiscal 2018 was primarily driven by the Company’s provisional SAB 118 adjustment of $60.3 million. The tax benefit in fiscal 2017 was primarily driven by the Company's corporate reorganization and the related non-cash reversal of a valuation allowance against net deferred tax assets. Prior to the fourth quarter of fiscal 2017, the Company was organized as a limited liability company and conducted its operations primarily through limited liability companies and Subchapter C corporations. As such, the Company's effective tax rate in periods prior to the corporate reorganization was largely driven by the mix of pre-tax income or loss between our taxable and nontaxable entities.

Segments: The Company and its subsidiaries offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel and other items and services in its stores or through eCommerce channels. The Company's operating divisions are geographically based, have similar economic characteristics and similar expected long-term financial performance. The Company's operating segments and reporting units are its 13 divisions, which have been aggregated into one reportable segment. Each reporting unit constitutes a business for which discrete financial information is available and for which management regularly reviews the operating results. Across all operating segments, the Company operates primarily one store format. Each store offers the same general mix of products with similar pricing to similar categories of customers, has similar distribution methods, operates in similar regulatory environments and purchases merchandise from similar or the same vendors. All of the Company's retail operations are domestic.

7


Table of Contents


Revenue Recognition: Revenues from the retail sale of products are recognized at the point of sale to the customer, net of returns and sales tax. Pharmacy sales are recorded upon the customer receiving the prescription. Third party receivables from pharmacy sales were $246.1 million and $205.5 million as of December 1, 2018 and February 24, 2018, respectively, and are recorded in Receivables, net. For eCommerce related sales, which primarily includes home delivery, "Drive Up and Go" stores and meal kit delivery, revenues are recognized upon either pickup in store or delivery to the customer and may include revenue for separately charged delivery services. Discounts provided to customers by the Company at the time of sale are recognized as a reduction in sales as the products are sold. Discounts provided to customers by vendors, usually in the form of coupons, are not recognized as a reduction in sales, provided the coupons are redeemable at any retailer that accepts coupons. The Company recognizes revenue and records a corresponding receivable from the vendor for the difference between the sales prices and the cash received from the customer. The Company records a contract liability when rewards are earned by customers in connection with the Company's loyalty programs. As rewards are redeemed or expire, the Company reduces the contract liability and recognizes revenue.

The Company records a contract liability when it sells its own proprietary gift cards. The Company records a sale when the customer redeems the gift card. The Company's gift cards do not expire. The Company reduces the contract liability and records revenue for the unused portion of gift cards ("breakage") in proportion to its customers' pattern of redemption, which the Company determined to be the historical redemption rate. The Company's contract liability related to gift cards was $58.2 million as of December 1, 2018 and $55.6 million as of February 24, 2018. Breakage amounts were immaterial for the 12 and 40 weeks ended December 1, 2018 and December 2, 2017, respectively.

Disaggregated Revenues

The following table represents sales revenue by type of similar product (dollars in millions):
 
12 weeks ended
 
40 weeks ended
 
December 1,
2018
 
December 2,
2017
 
December 1,
2018
 
December 2,
2017
 
Amount (1)
 
% of Total
 
Amount (1)
 
% of Total
 
Amount (1)
 
% of Total
 
Amount (1)
 
% of Total
Non-perishables (2)
$
6,032.9

 
43.6
%
 
$
6,039.9

 
44.4
%
 
$
20,186.0

 
43.4
%
 
$
20,278.6

 
44.3
%
Perishables (3)
5,596.5

 
40.5
%
 
5,453.1

 
40.2
%
 
19,099.1

 
41.0
%
 
18,783.6

 
40.9
%
Pharmacy
1,194.5

 
8.6
%
 
1,187.1

 
8.7
%
 
3,847.0

 
8.3
%
 
3,858.2

 
8.4
%
Fuel
831.3

 
6.0
%
 
739.6

 
5.4
%
 
2,785.4

 
6.0
%
 
2,399.3

 
5.2
%
Other (4)
185.2

 
1.3
%
 
179.5

 
1.3
%
 
600.4

 
1.3
%
 
571.2

 
1.2
%
Net sales and other revenue
$
13,840.4

 
100.0
%
 
$
13,599.2

 
100.0
%
 
$
46,517.9

 
100.0
%
 
$
45,890.9

 
100.0
%

(1) eCommerce related sales are included in the categories to which the revenue pertains.
(2) Consists primarily of general merchandise, grocery and frozen foods.
(3) Consists primarily of produce, dairy, meat, deli, floral and seafood.
(4) Consists primarily of lottery and various other commissions and other miscellaneous income.
Sale-Leaseback Transactions

On August 16, 2018, the Company completed the sale and leaseback of two of the Company’s distribution centers for an aggregate purchase price, net of closing costs, of approximately $290 million. In connection with the sale and leaseback, the Company entered into lease agreements for each of the properties for initial terms of 20 years. The aggregate initial annual rent payment for the properties will be approximately $17 million, and includes 1.5% annual rent increases over the initial 20-year term.


8


Table of Contents

Subsequent to the end of the third quarter of fiscal 2018, the Company completed the sale and leaseback of five of the Company’s distribution centers for an aggregate purchase price, net of closing costs, of approximately $660 million. The sale and leasebacks were completed in two separate transactions which closed on December 17, 2018 and January 2, 2019, respectively. In connection with the sale and leasebacks, the Company entered into lease agreements for each of the properties for initial terms of 15 to 20 years. The aggregate initial annual rent payment for the properties will be approximately $38 million and includes 1.50% to 1.75% annual rent increases over the initial lease terms.

Recently adopted accounting standards: In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-09, "Revenue from Contracts with Customers (Topic 606)". The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company adopted this guidance in the first quarter of fiscal 2018 on a modified retrospective basis, including implementing changes to processes and controls to comply with the new disclosure requirements. The adoption of this standard resulted in a decrease to accumulated deficit of $5.8 million. The adjustment relates to breakage on the unredeemed portion of the Company's gift cards, which are now recognized in proportion to customer redemptions of gift cards, rather than waiting until the likelihood of redemption becomes remote. Similar to previous guidance, in certain third-party arrangements where the Company had previously determined it acts as a principal versus an agent, the Company will continue to record revenue for these arrangements on a gross basis under the new guidance.

In March 2017, the FASB issued ASU 2017-07, "Compensation - Retirement Benefits (Topic 715) - Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost." The Company adopted this guidance in the first quarter of fiscal 2018 on a retrospective basis. This ASU requires an employer to report the service cost component of net pension and post-retirement expense in the same line as other compensation costs from services rendered by employees during the period. Other components of net pension and post-retirement expense are required to be presented in the income statement separately from the service cost component. For the 12 and 40 weeks ended December 2, 2017, the Company reclassified $6.1 million and $20.3 million, respectively, of non-service pension and post-retirement cost components to Other (income) expense from Selling and administrative expenses.

In November 2016, the FASB issued ASU 2016-18, "Statement of Cash Flows - Restricted Cash (Topic 230)". The Company adopted this guidance in the first quarter of fiscal 2018 on a retrospective basis. The new guidance requires that restricted cash be added to Cash and cash equivalents when reconciling the beginning and ending amounts on the Condensed Consolidated Statements of Cash Flows. The guidance also requires entities that report cash and cash equivalents and restricted cash separately on the Condensed Consolidated Balance Sheets to reconcile those amounts to the Condensed Consolidated Statements of Cash Flows. For the 40 weeks ended December 2, 2017, the adoption of this standard resulted in a decrease to Net cash used in investing activities and an increase to Net increase (decrease) in cash and cash equivalents and restricted cash of $1.4 million. The following table provides a reconciliation of the amount of Cash and cash equivalents reported on the Condensed Consolidated Balance Sheets to the total of Cash and cash equivalents and restricted cash shown on the Condensed Consolidated Statements of Cash Flows (in millions):
 
December 1,
2018
 
December 2,
2017
Cash and cash equivalents
$
462.6

 
$
473.3

Restricted cash
23.5

 
11.3

Cash and cash equivalents and restricted cash
$
486.1

 
$
484.6


In August 2017, the FASB issued ASU 2017-12, "Derivatives and Hedging (Topic 815)". The new guidance more closely aligns the results of cash flow and fair value hedge accounting with risk management activities through changes to both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedge results in the financial statements. The guidance expands hedge accounting for both nonfinancial and financial risk components and refines the measurement of hedge results to better reflect an entity’s hedging strategies. The Company

9


Table of Contents

elected to early adopt this ASU beginning the first day of fiscal 2018. The adoption of this guidance did not have a material impact on the Company's Condensed Consolidated Financial Statements.

In January 2016, the FASB issued ASU 2016-01, "Financial Instruments-Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities". The ASU is intended to improve the recognition and measurement of financial instruments. The Company adopted this guidance in the first quarter of fiscal 2018. The new guidance requires equity investments, other than those accounted for under the equity method, to be measured at fair value, with changes in fair value recognized in net income. The guidance also amends certain disclosure requirements associated with the fair value of financial instruments. The adoption of this guidance did not have a material impact on the Company's Condensed Consolidated Financial Statements.

In August 2018, the FASB issued ASU 2018-15, "Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40)". The ASU is intended to improve the recognition and measurement of financial instruments. The new guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The Company elected to early adopt this ASU in the second quarter of fiscal 2018 on a prospective basis. The adoption of this guidance did not have a material impact on the Company's Condensed Consolidated Financial Statements.

Recently issued accounting standards: In February 2016, the FASB issued ASU 2016-02, "Leases (Topic 842)". The ASU will require organizations that lease assets to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. The new guidance will require both classifications of leases, operating and capital, to be recognized on the balance sheet. Consistent with current GAAP, the recognition, measurement and presentation of expenses and cash flows arising from a lease will depend on its classification. The ASU also will require disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. The Company plans to adopt this guidance in the first quarter of fiscal 2019. The Company plans to apply the practical expedients permitted within the guidance, which allows the Company to carryforward its historical lease classification, and to apply the transition option which does not require application of the guidance to comparative periods in the year of adoption. The adoption of this ASU will result in the recognition of significant right-of-use assets and lease liabilities in the Company’s Consolidated Balance Sheets. The Company has formed a dedicated project team and developed a comprehensive multi-stage project plan to assess and implement this ASU. This assessment includes reviewing all forms of leases and leveraging a technology solution in implementing the new ASU. The preparation for adoption is ongoing, including the assessment of other potential impacts of this ASU, which includes analysis of the potential transitional adjustments to Stockholders' equity and impact of adoption on the Consolidated Statements of Operations and the Consolidated Statements of Cash Flows.

In February 2018, the FASB issued ASU 2018-02, "Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income". This ASU amends ASC 220, "Income Statement - Reporting Comprehensive Income", to allow a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Act. In addition, under the ASU, the Company may be required to provide certain disclosures regarding stranded tax effects. The ASU will take effect for public entities for annual reporting periods beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the effect of the standard on its Consolidated Financial Statements.

NOTE 2 - ACQUISITIONS

Termination of Merger Agreement with Rite Aid

As previously disclosed, on February 18, 2018, the Company and its wholly-owned subsidiaries, Ranch Acquisition II LLC and Ranch Acquisition Corp. (together with Ranch Acquisition II LLC, "Merger Subs") and Rite Aid Corporation ("Rite Aid") entered into an Agreement and Plan of Merger (the "Merger Agreement"). On August 8, 2018, the Company,

10


Table of Contents

Merger Subs and Rite Aid entered into a Termination Agreement (the "Termination Agreement") under which the parties mutually agreed to terminate the Merger Agreement. Subject to limited customary exceptions, the Termination Agreement also mutually releases the parties from any claims of liability to one another relating to the contemplated merger transaction. Under the terms of the Merger Agreement, neither the Company nor Rite Aid will be responsible for any payments to the other party as a result of the termination of the Merger Agreement.

In addition, as result of the above termination, that certain Second Amended & Restated Commitment Letter, dated May 8, 2018, by and among the Company, Bank of America, N.A., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Credit Suisse AG, Credit Suisse Loan Funding LLC, Goldman Sachs Bank USA and the other commitment parties thereto terminated automatically pursuant to its terms.

NOTE 3 - FAIR VALUE MEASUREMENTS
The accounting guidance for fair value established a framework for measuring fair value and established a three-level valuation hierarchy for disclosure of fair value measurement. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability at the measurement date. The three levels are defined as follows:
Level 1 -
Quoted prices in active markets for identical assets or liabilities;
Level 2 -
Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable;
Level 3 -
Unobservable inputs in which little or no market activity exists, requiring an entity to develop its own assumptions that market participants would use to value the asset or liability.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

The following table presents assets and liabilities which were measured at fair value on a recurring basis as of December 1, 2018 (in millions):
 
 
Fair Value Measurements
 
 
Total
 
Quoted prices in active markets
 for identical assets
(Level 1)
 
Significant
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
 
Cash equivalents:
 
 
 
 
 
 
 
 
Money market
 
$
44.0

 
$
44.0

 
$

 
$

Short-term investments (1)
 
23.2

 
21.1

 
2.1

 

Non-current investments (2)
 
89.1

 
36.9

 
52.2

 

Derivative contracts (3)
 
3.4

 

 
3.4

 

Total
 
$
159.7

 
$
102.0

 
$
57.7

 
$

 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
Contingent consideration (4)
 
$
19.9

 
$

 
$

 
$
19.9

Total
 
$
19.9

 
$

 
$

 
$
19.9

(1) Primarily relates to Mutual Funds. Included in Other current assets.
(2) Primarily relates to investments in publicly traded stock classified as available for sale (Level 1) and U.S. Treasury Notes and Corporate Bonds (Level 2). Included in Other assets.
(3) Primarily relates to interest rate swaps. Included in Other current assets.

11


Table of Contents

(4) Included in Other long-term liabilities.
The following table presents assets and liabilities which were measured at fair value on a recurring basis as of February 24, 2018 (in millions):
 
 
Fair Value Measurements
 
 
Total
 
Quoted prices in active markets
 for identical assets
(Level 1)
 
Significant
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
 
Cash equivalents:
 
 
 
 
 
 
 
 
Money market
 
$
198.0

 
$
198.0

 
$

 
$

Short-term investments (1)
 
24.5

 
22.1

 
2.4

 

Non-current investments (2)
 
91.2

 
40.2

 
51.0

 

Total
 
$
313.7

 
$
260.3

 
$
53.4

 
$

 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
Derivative contracts (3)
 
$
11.8

 
$

 
$
11.8

 
$

Contingent consideration (4)
 
60.0

 

 

 
60.0

Total
 
$
71.8

 
$

 
$
11.8

 
$
60.0


(1) Primarily relates to Mutual Funds. Included in Other current assets.
(2) Primarily relates to investments in publicly traded stock classified as available for sale (Level 1) and U.S. Treasury Notes and Corporate Bonds (Level 2). Included in Other assets.
(3) Primarily relates to interest rate swaps. Included in Other current liabilities.
(4) Included in Other current liabilities and Other long-term liabilities.
A reconciliation of the beginning and ending balances for Level 3 liabilities follows (in millions):
 
Contingent Consideration
 
December 1, 2018
Beginning balance
$
60.0

Change in fair value
(39.4
)
Payments
(0.7
)
Ending balance
$
19.9


The estimated fair value of the Company’s debt, including current maturities, was based on Level 2 inputs, being market quotes or values for similar instruments, and interest rates currently available to the Company for the issuance of debt with similar terms and remaining maturities as a discount rate for the remaining principal payments. As of December 1, 2018, the fair value of total debt was $9,975.7 million compared to the carrying value of $10,468.1 million, excluding debt discounts and deferred financing costs. As of February 24, 2018, the fair value of total debt was $10,603.4 million compared to the carrying value of $11,340.5 million, excluding debt discounts and deferred financing costs.
Assets Measured at Fair Value on a Non-Recurring Basis

The Company measures certain assets at fair value on a non-recurring basis, including long-lived assets and goodwill, which are evaluated for impairment. Long-lived assets include store-related assets such as property and equipment and certain intangible assets. The inputs used to determine the fair value of long-lived assets and a reporting unit are considered Level 3 measurements due to their subjective nature.


12


Table of Contents

NOTE 4 - DERIVATIVE FINANCIAL INSTRUMENTS
Interest Rate Risk Management

The Company is exposed to market risk from fluctuations in interest rates. The Company manages its exposure to interest rate fluctuations through the use of interest rate swaps ("cash flow hedges"). The Company’s risk management objective and strategy with respect to interest rate swaps is to protect the Company against adverse fluctuations in interest rates by reducing its exposure to variability in cash flows relating to interest payments on a portion of its outstanding debt. The Company is meeting its objective by hedging the risk of changes in its cash flows (interest payments) attributable to changes in the London Inter-Bank Offering Rate ("LIBOR"), the designated benchmark interest rate being hedged (the "hedged risk"), on an amount of the Company's debt principal equal to the then-outstanding swap notional amount.
Cash Flow Interest Rate Swaps

For derivative instruments that are designated and qualify as cash flow hedges of forecasted interest payments, the Company reports the gain or loss as a component of Other comprehensive income until the interest payments being hedged are recorded as Interest expense, net, at which time the amounts in Other comprehensive income are reclassified as an adjustment to Interest expense, net. The Company has entered into several swaps with maturity dates in 2019 and 2021 to hedge against variability in cash flows relating to interest payments on a portion of the Company's outstanding variable rate term debt. The aggregate notional amounts of all swaps as of both December 1, 2018 and February 24, 2018 were $3,110.0 million, of which $3,052.0 million are designated as cash flow hedges as defined by GAAP. The undesignated portion of the Company's interest rate swaps is attributable to principal payments expected to be made through the loan’s maturity.

On June 20, 2018, the Company entered into two new interest rate swap agreements with notional amounts of $339.0 million and $254.0 million, with an effective date of March 2019 and maturing in March 2023. These swaps hedge against variability in cash flows relating to interest payments on the Company’s outstanding variable rate debt. Accordingly, the interest rate swaps will be designated as cash flow hedges as defined by GAAP.

As of December 1, 2018, the fair value of the cash flow interest rate swap asset was $3.4 million and was recorded in Other current assets, and as of February 24, 2018, the fair value of the cash flow interest rate swap liability was $13.0 million and was recorded in Other current liabilities.


13


Table of Contents

Activity related to the Company’s derivative instruments designated as cash flow hedges consisted of the following (in millions):
 
 
Amount of income recognized from derivatives
 
 
Derivatives designated as hedging instruments
 
12 weeks ended December 1, 2018

12 weeks ended December 2, 2017
 
Location of income recognized from derivatives
Designated interest rate swaps
 
$
0.9

 
$
22.2

 
Other comprehensive income (loss), net of tax
 
 
Amount of income recognized from derivatives
 
 
Derivatives designated as hedging instruments
 
40 weeks ended December 1, 2018
 
40 weeks ended December 2, 2017
 
Location of income recognized from derivatives
Designated interest rate swaps
 
$
4.3

 
$
22.6

 
Other comprehensive income (loss), net of tax


Activity related to the Company’s derivative instruments not designated as hedging instruments was immaterial during the 12 and 40 weeks ended December 1, 2018 and December 2, 2017, respectively.

NOTE 5 - LONG-TERM DEBT AND CAPITALIZED LEASE OBLIGATIONS
The Company’s long-term debt as of December 1, 2018 and February 24, 2018, net of unamortized debt discounts of $215.7 million and $249.6 million, respectively, and deferred financing costs of $58.9 million and $79.7 million, respectively, consisted of the following (in millions):
 
December 1,
2018
 
February 24,
2018
Albertsons Term Loans due 2022 to 2025, interest rate range of 4.32% to 5.69%
$
4,614.6

 
$
5,610.7

Senior Unsecured Notes due 2024 and 2025, interest rate of 6.625% and 5.750%, respectively
2,478.8

 
2,476.1

New Albertson's, L.P. Notes due 2027 to 2031, interest rate range of 6.52% to 8.70%
1,402.8

 
1,393.9

Safeway Inc. Notes due 2019 to 2031, interest rate range of 3.95% to 7.45%
944.4

 
1,266.9

ABL Facility, average interest rate of 3.60%
610.0

 

Other Notes Payable, unsecured
124.0

 
242.7

Mortgage Notes Payable, secured
18.9

 
20.9

Total debt
10,193.5

 
11,011.2

Less current maturities
(315.1
)
 
(66.1
)
Long-term portion
$
9,878.4

 
$
10,945.1


The Company's term loans (the "Albertsons Term Loans"), asset-based loan ("ABL") facility (the "ABL Facility") and certain of the outstanding notes and debentures have restrictive covenants, subject to the right to cure in certain circumstances, calling for the acceleration of payments due in the event of a breach of a covenant or a default in the payment of a specified amount of indebtedness due under certain debt arrangements. There are no restrictions on the Company's ability to receive distributions from its subsidiaries to fund interest and principal payments due under the

14


Table of Contents

ABL Facility, the Albertsons Term Loans and the Company's senior unsecured notes (the "Senior Unsecured Notes"). Each of the ABL Facility, Albertsons Term Loans and the Senior Unsecured Notes restrict the ability of the Company to pay dividends and distribute property to the Company's stockholders. As a result, all of the Company's consolidated net assets are effectively restricted with respect to their ability to be transferred to the Company's stockholders. Notwithstanding the foregoing, the ABL Facility, Albertsons Term Loans and the Senior Unsecured Notes each contain customary exceptions for certain dividends and distributions, including the ability to make cumulative distributions under the Albertsons Term Loans and Senior Unsecured Notes of up to the greater of $1.0 billion or 4% of the Company's total assets (which is measured at the time of such distribution) and the ability to make distributions if certain payment conditions are satisfied under the ABL Facility. The Company was in compliance with all such covenants and provisions as of and for the 40 weeks ended December 1, 2018.
Term Loan Refinancing
On November 16, 2018, the Company repaid approximately $976 million in aggregate principal amount of the $2,976 million term loan tranche B-4 (the "2017 Term Loan B-4") along with accrued interest and unpaid interest on such amount and fees and expenses related to the Term Loan Repayment and the 2018 Term Loan B-7 (each as defined below), for which the Company used approximately $610 million of cash on hand and approximately $410 million of borrowings under the ABL Facility (such repayment, the "Term Loan Repayment"). Substantially concurrently with the Term Loan Repayment, the Company amended the Company's Second Amended and Restated Term Loan Agreement, dated as of August 25, 2014 and effective as of January 30, 2015 (as amended, the "Term Loan Agreement"), to establish a new term loan tranche and amend certain provisions of the Term Loan Agreement. The new tranche consists of $2,000 million of new term B-7 loans (the "2018 Term Loan B-7"). The 2018 Term Loan B-7, together with cash on hand, was used to repay in full the remaining principal amount outstanding under the 2017 Term Loan B-4 (the "2018 Term Loan Refinancing"). The 2018 Term Loan Refinancing was accounted for as a debt modification or extinguishment on a lender by lender basis. In connection with the 2018 Term Loan Refinancing and Term Loan Repayment, the Company expensed $4.1 million of financing costs and capitalized $3.6 million of financing costs and $15.0 million of original issue discount. The Company also wrote off $12.9 million of deferred financing costs and $8.6 million of original issue discount associated with the 2017-1 Term B-4 Loan. The 2018 Term Loan B-7 has a maturity date of November 17, 2025. The 2018 Term Loan B-7 amortizes, on a quarterly basis, at a rate of 1% per annum of the original principal amount of the 2018 Term Loan B-7 (which payments will be reduced as a result of the application of prepayments in accordance with the terms therewith). The 2018 Term Loan B-7 bears interest, at the borrower's option, at a rate per annum equal to either (a) the base rate plus 2.00% or (b) LIBOR (subject to a 0.75% floor) plus 3.00%.
Safeway Notes
During the third quarter of fiscal 2018, Safeway Inc., a wholly-owned subsidiary of the Company, repurchased certain amounts of Safeway Inc.'s 7.450% Senior Debentures due 2027 and 7.250% Debentures due 2031 with a par value of $333.7 million and a book value of $322.4 million for $333.7 million plus accrued interest of $7.7 million ("Safeway Notes Repurchase"). In connection with the Safeway Notes Repurchase, the Company recorded a loss on debt extinguishment of $11.3 million.
NALP Notes
During the third quarter of fiscal 2018, the Company repurchased NALP Notes with a par value of $10.4 million and a book value of $10.4 million for $8.6 million plus accrued interest of $0.2 million ("NALP Notes Repurchase"). In connection with the NALP Notes Repurchase, the Company recorded a gain on debt extinguishment of $1.8 million.

15


Table of Contents

Asset-Based Loan Facility

On November16, 2018, the existing ABL Facility was amended and restated in connection with the 2018 Term Loan Refinancing to extend the maturity date of the facility to November 16, 2023. All other terms of the agreement remain unchanged. In connection with the ABL Facility amendment the Company capitalized $13.5 million of financing costs.
As of December 1, 2018, there were $610.0 million of loans outstanding under the Company's ABL Facility, and letters of credit ("LOC") issued under the LOC sub-facility were $561.2 million. There were no loans outstanding under the Company's ABL Facility as of February 24, 2018, and letters of credit ("LOC") issued under the LOC sub-facility were $576.8 million.
Capitalized Lease Obligations
The Company's capitalized lease obligations were $784.4 million and $864.6 million as of December 1, 2018 and February 24, 2018, respectively. Current maturities of capitalized lease obligations were $97.5 million and $102.1 million and long-term maturities were $686.9 million and $762.5 million as of December 1, 2018 and February 24, 2018, respectively.
Merger Related Financing

On June 25, 2018 the Company issued $750.0 million in aggregate principal amount of floating rate senior secured notes (the "Floating Rate Notes") at an issue price of 99.5%. As a result of the Termination Agreement with Rite Aid on August 8, 2018, the Company redeemed all of the Floating Rate Notes at a redemption price equal to 99.5% of the aggregate principal amount of the notes, plus accrued and unpaid interest.


16


Table of Contents

NOTE 6 - EMPLOYEE BENEFIT PLANS
Pension and Other Post-Retirement Benefits

The following tables provide the components of net pension and post-retirement expense (in millions):
 
12 weeks ended
 
Pension
 
Other post-retirement benefits
 
December 1,
2018
 
December 2,
2017
 
December 1,
2018
 
December 2,
2017
Estimated return on plan assets
$
(26.0
)
 
$
(27.6
)
 
$

 
$

Service cost
12.1

 
11.5

 
0.3

 
0.3

Interest cost
19.8

 
20.4

 
0.1

 
0.2

Amortization of prior service cost

 

 
0.8

 
0.8

Amortization of net actuarial (gain) loss
(1.4
)
 
0.1

 
(0.1
)
 

Net expense
$
4.5

 
$
4.4

 
$
1.1

 
$
1.3

 
40 weeks ended
 
Pension
 
Other post-retirement benefits
 
December 1,
2018
 
December 2,
2017
 
December 1,
2018
 
December 2,
2017
Estimated return on plan assets
$
(86.6
)
 
$
(92.0
)
 
$

 
$

Service cost
40.3

 
38.3

 
0.8

 
0.8

Interest cost
66.0

 
67.9

 
0.4

 
0.7

Amortization of prior service cost

 
0.1

 
2.8

 
2.8

Amortization of net actuarial (gain) loss
(4.8
)
 
0.3

 
(0.2
)
 

Net expense
$
14.9

 
$
14.6

 
$
3.8

 
$
4.3



The Company contributed $186.4 million and $196.9 million to its defined benefit pension plans and post-retirement benefit plans during the 12 and 40 weeks ended December 1, 2018, respectively. For the 12 and 40 weeks ended December 2, 2017, the Company contributed $13.4 million and $19.8 million, respectively, to its defined benefit pension plans and post-retirement benefit plans. The Company's funding policy for the defined benefit pension plans is to contribute the minimum contribution required under the Employee Retirement Income Security Act of 1974, as amended, and other applicable laws as determined by the Company's external actuarial consultant. At the Company's discretion, additional funds may be contributed to the defined benefit pension plans. The Company's fiscal 2018 contributions include $150.0 million of additional discretionary contributions to reduce the Pension Benefit Guaranty Corporation premium costs and improve the overall funded status of the plan. The Company currently anticipates contributing an additional $2.5 million to these plans for the remainder of fiscal 2018.

The Company also contributes to various multiemployer pension plans based on obligations arising from most of its collective bargaining agreements. These plans provide retirement benefits to participants based on their service to contributing employers. The Company recognizes expense in connection with these plans as contributions are funded.
Defined Contribution Plans and Supplemental Retirement Plans

Many of the Company's employees are eligible to contribute a percentage of their compensation to defined contribution plans ("401(k) Plans"). Participants in the 401(k) Plans may become eligible to receive a profit-sharing allocation in the form of a discretionary Company contribution based on employee compensation. In addition, the Company may also provide matching contributions based on the amount of eligible compensation contributed by the employee. All Company contributions to the 401(k) Plans are made at the discretion of the Company's Board of Directors. Total contributions expensed for these plans were $11.7 million and $9.4 million for the 12 weeks ended December 1, 2018

17


Table of Contents

and December 2, 2017, respectively. For the 40 weeks ended December 1, 2018 and December 2, 2017, total contributions expensed were $32.2 million and $32.6 million, respectively.

NOTE 7 - COMMITMENTS AND CONTINGENCIES AND OFF BALANCE SHEET ARRANGEMENTS
Guarantees

California Department of Industrial Relations: On October 24, 2012, the Office of Self-Insurance Plans, a program within the director's office of the California Department of Industrial Relations (the "DIR"), notified SuperValu, which was then the owner of New Albertsons L.P., a wholly-owned subsidiary of the Company, that additional collateral was required to be posted in connection with the Company's, and certain other subsidiaries', California self-insured workers’ compensation obligations pursuant to applicable regulations. The notice from the DIR stated that the additional collateral was required as a result of an increase in estimated future liabilities, as determined by the DIR pursuant to a review of the self-insured California workers' compensation claims with respect to the applicable businesses, and a decline in SuperValu’s net worth. On January 21, 2014, the Company entered into a Collateral Substitution Agreement with the California Self-Insurers' Security Fund to provide an irrevocable LOC. The amount of the LOC is adjusted semi-annually based on semi-annual filings of an actuarial study reflecting liabilities as of and June 30 and December 31 of each year reduced by claim closures and settlements. The related LOC was $183.0 million and $205.6 million as of December 1, 2018 and February 24, 2018, respectively.

Lease Guarantees: The Company may have liability under certain operating leases that were assigned to third parties. If any of these third parties fail to perform their obligations under the leases, the Company could be responsible for the lease obligation. Because of the wide dispersion among third parties and the variety of remedies available, the Company believes that if an assignee became insolvent, it would not have a material effect on the Company's financial condition, results of operations or cash flows.

The Company also provides guarantees, indemnifications and assurances to others in the ordinary course of its business.
Legal Proceedings

The Company is subject from time to time to various claims and lawsuits arising in the ordinary course of business, including lawsuits involving trade practices, lawsuits alleging violations of state and/or federal wage and hour laws (including alleged violations of meal and rest period laws and alleged misclassification issues), real estate disputes as well as other matters. Some of these suits purport or may be determined to be class actions and/or seek substantial damages. It is the opinion of the Company's management that although the amount of liability with respect to certain of the matters described herein cannot be ascertained at this time, any resulting liability of these and other matters, including any punitive damages, will not have a material adverse effect on the Company's business or financial condition.

The Company continually evaluates its exposure to loss contingencies arising from pending or threatened litigation and believes it has made provisions where the loss contingency can be reasonably estimated and an adverse outcome is probable. Nonetheless, assessing and predicting the outcomes of these matters involves substantial uncertainties. Management currently believes that the aggregate range of reasonably possible loss for the Company's exposure in excess of the amount accrued is expected to be immaterial to the Company. It remains possible that despite management's current belief, material differences in actual outcomes or changes in management’s evaluation or predictions could arise that could have a material effect on the Company's financial condition, results of operations or cash flows.

Office of Inspector General: In January 2016, the Company received a subpoena from the Office of the Inspector General of the Department of Health and Human Services (the "OIG") pertaining to the pricing of drugs offered under the Company’s MyRxCare discount program and the impact on reimbursements to Medicare, Medicaid and TRICARE (the "Government Health Programs"). In particular, the OIG is requesting information on the relationship between the

18


Table of Contents

prices charged for drugs under the MyRxCare program and the "usual and customary" prices reported by the Company in claims for reimbursements to the Government Health Programs or other third-party payors. The Company cooperated with the OIG in the investigation. The Company is currently unable to determine the probability of the outcome of this matter or the range of reasonably possible loss, if any.

Civil Investigative Demand: On December 16, 2016, the Company received a civil investigative demand from the United States Attorney for the District of Rhode Island in connection with a False Claims Act investigation relating to the Company's influenza vaccination programs. The investigation concerns whether the Company's provision of store coupons to its customers who received influenza vaccinations in its store pharmacies constituted an improper benefit to those customers under the federal Medicare and Medicaid programs. The Company believes that its provision of the store coupons to its customers is an allowable incentive to encourage vaccinations. The Company cooperated with the U.S. Attorney in the investigation. The Company is currently unable to determine the probability of the outcome of this matter or the range of possible loss, if any.

Security Breach: In 2014, the Company was the subject of criminal intrusions by the installation of malware on a portion of its computer network that processes payment card transactions for approximately 800 of its stores through its then service provide SuperValu. The Company believes these were attempts to collect payment card data. The forensic investigation into the intrusions indicated that although the Company was then compliant with the Payment Card Industry (PCI) Data Security Standards issued by the PCI Council, it was not compliant with all of these standards at the time of the intrusions. As a result, the Company was assessed by certain card companies for incremental counterfeit fraud losses, non-ordinary course expenses (such as card reissuance cost) and case management costs. The Company has paid or recorded an estimated liability for all of such assessments, and is seeking recovery from MasterCard of its assessment. As a result of the intrusion two class action complaints were filed against the Company by consumers. These complaints have been dismissed, although the appeal of the dismissal of one case remains pending. In 2015 the Company also received a letter from the Office of the Attorney General of the Commonwealth of Pennsylvania stating that the Illinois and Pennsylvania Attorneys General Offices were leading a multi-state group requesting specified information concerning the two data breach incidents. The Company has cooperated with the investigation. The multistate group did not make a monetary demand, and the Company is unable to estimate the possibility or range of loss, if any.

Terraza/Lorenz: Two lawsuits have been brought against Safeway Inc. and the Safeway Benefits Plan Committee (the "Benefit Plans Committee," and together with Safeway, the "Safeway Benefits Plans Defendants") and other third parties alleging breaches of fiduciary duty under the Employee Retirement Income Security Act of 1974, as amended ("ERISA") with respect to Safeway’s 401(k) Plan (the "Safeway 401(k) Plan"). On July 14, 2016, a complaint ("Terraza") was filed in the United States District Court for the Northern District of California by a participant in the Safeway 401(k) Plan individually and on behalf of the Safeway 401(k) Plan. An amended complaint was filed on November 18, 2016. On August 25, 2016, a second complaint ("Lorenz") was filed in the United States District Court for the Northern District of California by another participant in the Safeway 401(k) Plan individually and on behalf of all others similarly situated against the Safeway Benefits Plans Defendants and against the Safeway 401(k) Plan’s former recordkeepers. An amended complaint was filed on September 16, 2016, and a second amended complaint was filed on November 21, 2016. In general, both lawsuits allege that the Safeway Benefits Plans Defendants breached their fiduciary duties under ERISA regarding the selection of investments offered under the Safeway 401(k) Plan and the fees and expenses related to those investments. The Safeway Benefits Plans Defendants filed motions to dismiss both cases. On March 13, 2017, the court denied the Safeway Benefits Plan Defendants' motion to dismiss with respect to Terraza, and granted in part and denied in part the Safeway Benefits Plan Defendants' motion to dismiss with respect to Lorenz. Discovery closed on June 8, 2018. The parties filed summary judgment motions, which were heard and taken under submission on August 16, 2018. Bench trials for both matters had been set for October 2018, but the judge rescheduled both trials to May 6, 2019. The Company believes these lawsuits are without merit and intends to contest each of them vigorously. Because the question of liability, if any, is uncertain, the Company is currently unable to estimate a range of reasonably possible loss, if any, that may result from these matters


19


Table of Contents

False Claims Act: The Company is currently subject to two qui tam actions alleging violations of the False Claims Act ("FCA"). Violations of the FCA are subject to treble damages and penalties of up to a specified dollar amount per false claim. In United States ex rel. Schutte and Yarberry v. SuperValu, New Albertson's, Inc., et al, which is pending in the U.S. District Court for the Central District of Illinois, the relators allege that defendants (including various subsidiaries of the Company) overcharged federal healthcare programs by not providing the government, as a part of usual and customary prices, the benefit of discounts given to customers who requested that defendants match competitor prices. The complaint was originally filed under seal and amended on November 30, 2015. Both sides have moved for summary judgment, and motions are pending before the court. Discovery is substantially complete, and trial is currently set for April 3, 2019. In United States ex rel. Proctor v. Safeway, also pending in the Central District of Illinois, the relator alleges that Safeway Inc. submitted fraudulent, inflated pricing information to government healthcare programs in connection with prescription drug claims, by failing to include pharmacy discount program pricing as a part of its usual and customary prices. On August 26, 2015, the underlying complaint was unsealed. Discovery is substantially complete, and trial is currently set for March 4, 2019. In both of the above cases, the government previously investigated the relators' allegations and declined to intervene. Relators elected to pursue their respective cases on their own and in each case have alleged FCA damages in excess of $100 million. The Company is vigorously defending each of these matters and believes each of these cases is without merit. At this stage of each case's proceedings the Company is unable to determine the probability of the outcome of this matter or the range of reasonably possible loss, if any.
 
The Company was also subject to another FCA qui tam action entitled United States ex rel. Zelickowski v. Albertson's LLC. In that case, the relators alleged that Albertson's LLC overcharged federal healthcare programs by not providing the government, as a part of its usual and customary prices to the government, the benefit of discounts given to customers who enrolled in the Albertson's LLC discount-club program. The complaint was originally filed under seal and amended on June 20, 2017. On December 17, 2018, the case was dismissed, without prejudice.

Alaska Attorney General's Investigation: Recently, pharmaceutical manufacturers, wholesale distributors and retailers have faced intense scrutiny and, in some cases, investigations and litigation relating to the distribution of prescription opioid pain medications. On May 22, 2018, the Company received a subpoena from the Office of the Attorney General for the State of Alaska (the "Alaska Attorney General") stating that the Alaska Attorney General has reason to believe the Company has engaged in unfair or deceptive trade practices under Alaska’s Unfair Trade Practices and Consumer Act and seeking documents regarding the Company's policies, procedures, controls, training, dispensing practices and other matters in connection with the sale and marketing of opioid pain medications. The Company has been cooperating with the Alaska Attorney General in this investigation. The Company does not currently have a basis to believe it has violated Alaska’s Unfair Trade Practices and Consumer Act. However, due to the early stages of the investigation, the Company is unable to determine the probability of the outcome of this matter or estimate a range of reasonably possible loss, if any.

Opioid Litigation: Albertson’s LLC has been named in a complaint brought by The Blackfeet Tribe of the Blackfeet Indian Reservation.  The complaint was filed on August 29, 2018 in the United States District Court for the Northern District of Ohio as one of 62 cases consolidated under rules governing multidistrict litigation. The Company was served with the complaint on January 11, 2019. The complaint asserts unspecified allegations that the Company contributed to the national opioid situation.  As a drug retailer that only dispenses medication as prescribed by licensed physicians, the Company believes that the claims are factually inaccurate and without merit.

Other Commitments

In the ordinary course of business, the Company enters into various supply contracts to purchase products for resale and purchase and service contracts for fixed asset and information technology commitments. These contracts typically include volume commitments or fixed expiration dates, termination provisions and other standard contractual considerations.


20


Table of Contents

NOTE 8 - OTHER COMPREHENSIVE INCOME OR LOSS

Total comprehensive earnings are defined as all changes in stockholders' equity during a period, other than those from investments by or distributions to the stockholders. Generally, for the Company, total comprehensive income or loss equals net income plus or minus adjustments for pension and other post-retirement liabilities, interest rate swaps and foreign currency translation adjustments. Total comprehensive earnings represent the activity for a period net of tax.

While total comprehensive earnings are the activity in a period and are largely driven by net earnings in that period, accumulated other comprehensive income or loss ("AOCI") represents the cumulative balance of other comprehensive income, net of tax, as of the balance sheet date. Changes in the AOCI balance by component are shown below (in millions):
 
40 weeks ended December 1, 2018
 
Total
 
Interest rate swaps
 
Pension and Post-retirement benefit plans
 
Foreign currency translation adjustments
 
Other
Beginning balance
$
191.1

 
$
18.9

 
$
171.9

 
$
(1.1
)
 
$
1.4

Other comprehensive income (loss) before reclassifications
3.8

 
5.5

 

 
(0.4
)
 
(1.3
)
Amounts reclassified from accumulated other comprehensive income
(2.5
)
 
0.4

 
(2.2
)
 

 
(0.7
)
Tax (expense) benefit
(0.3
)
 
(1.6
)
 
0.6

 
0.1

 
0.6

Current-period other comprehensive income (loss), net
1.0

 
4.3

 
(1.6
)
 
(0.3
)
 
(1.4
)
Ending balance
$
192.1

 
$
23.2

 
$
170.3

 
$
(1.4
)
 
$

 
40 weeks ended December 2, 2017
 
Total
 
Interest rate swaps
 
Pension and Post-retirement benefit plans
 
Foreign currency translation adjustments
 
Other
Beginning balance
$
(12.8
)
 
$
(28.1
)
 
$
79.7

 
$
(66.1
)
 
$
1.7

Other comprehensive income before reclassifications
32.4

 
4.8

 
2.2

 
23.7

 
1.7

Amounts reclassified from accumulated other comprehensive income
25.7

 
27.9

 
2.8

 

 
(5.0
)
Tax (expense) benefit
(18.8
)
 
(10.1
)
 
1.0

 
(9.4
)
 
(0.3
)
Current-period other comprehensive income (loss), net
39.3

 
22.6

 
6.0

 
14.3

 
(3.6
)
Ending balance
$
26.5

 
$
(5.5
)
 
$
85.7

 
$
(51.8
)
 
$
(1.9
)



21


Table of Contents




Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report contains forward-looking statements. All statements other than statements of historical facts contained in this Quarterly Report, including statements regarding our future operating results and financial position, business strategy and plans and objectives of management for future operations, are forward-looking statements. In many cases, you can identify forward-looking statements by terms such as "may," "should," "expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," or "continue" or the negative of these terms or other similar expressions. Forward-looking statements are based on our current expectations and assumptions and involve risks and uncertainties that could cause actual results or events to be materially different from those anticipated. The Company undertakes no obligation to update or revise any such statements as a result of new information, future events or otherwise. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments we may make. As used in this Form 10-Q, unless the context otherwise requires, references to "Albertsons", "the Company", "we", "us" and "our" refer to Albertsons Companies, Inc. and, where appropriate, its subsidiaries.

NON-GAAP FINANCIAL MEASURES
We define EBITDA as generally accepted accounting principles ("GAAP") earnings (net loss) before interest, income taxes, depreciation, and amortization. We define Adjusted EBITDA as earnings (net loss) before interest, income taxes, depreciation, and amortization, further adjusted to eliminate the effects of items management does not consider in assessing our ongoing performance. We define Free Cash Flow as Adjusted EBITDA less capital expenditures. See "Results of Operations" for further discussion and a reconciliation of Adjusted EBITDA and Free Cash Flow.

EBITDA, Adjusted EBITDA and Free Cash Flow (collectively, the "Non-GAAP Measures") are performance measures that provide supplemental information we believe is useful to analysts and investors to evaluate our ongoing results of operations, when considered alongside other GAAP measures such as net income, operating income and gross profit. These Non-GAAP Measures exclude the financial impact of items management does not consider in assessing our ongoing operating performance, and thereby facilitate review of our operating performance on a period-to-period basis. Other companies may have different capital structures or different lease terms, and comparability to our results of operations may be impacted by the effects of acquisition accounting on our depreciation and amortization. As a result of the effects of these factors and factors specific to other companies, we believe EBITDA, Adjusted EBITDA and Free Cash Flow provide helpful information to analysts and investors to facilitate a comparison of our operating performance to that of other companies. We also use Adjusted EBITDA, as further adjusted for additional items defined in our debt instruments, for board of director and bank compliance reporting. Our presentation of Non-GAAP Measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.

Non-GAAP Measures should not be considered as measures of discretionary cash available to us to invest in the growth of our business. We compensate for these limitations by relying primarily on our GAAP results and using Non-GAAP Measures only for supplemental purposes.

OVERVIEW
As of December 1, 2018, we operated 2,277 retail food and drug stores with 1,743 pharmacies, 395 associated fuel centers, 23 dedicated distribution centers, five Plated fulfillment centers and 20 manufacturing facilities. In addition to our retail footprint, we continue to roll out unique options for our customers as we strive to differentiate through our best in class Own Brands and rapidly expanding eCommerce options, which primarily include home delivery sales, "Drive Up and Go" stores and Plated meal kit delivery.

22


Table of Contents




The following table shows stores operating, acquired, opened and closed during the periods presented:
 
12 weeks ended
 
40 weeks ended
 
December 1,
2018
 
December 2,
2017
 
December 1,
2018
 
December 2,
2017
Stores, beginning of period
2,291

 
2,328

 
2,318

 
2,324

Acquired

 

 

 
5

Opened

 
1

 
3

 
13

Closed
(14
)
 
(6
)
 
(44
)
 
(19
)
Stores, end of period
2,277

 
2,323

 
2,277

 
2,323

The following table summarizes our stores by size:
 
 
Number of stores
 
Percent of Total
 
Retail Square Feet (1)
Square Footage
 
December 1,
2018
 
December 2,
2017
 
December 1,
2018
 
December 2,
2017
 
December 1,
2018
 
December 2,
2017
Less than 30,000
 
208

 
213

 
9.1
%
 
9.2
%
 
4.8

 
4.9

30,000 to 50,000
 
795

 
813

 
34.9
%
 
35.0
%
 
33.4

 
34.1

More than 50,000
 
1,274

 
1,297

 
56.0
%
 
55.8
%
 
75.2

 
76.5

Total Stores
 
2,277

 
2,323

 
100.0
%
 
100.0
%
 
113.4

 
115.5

(1) In millions, reflects total square footage of retail stores operating at the end of the quarter.

 

23


Table of Contents




RESULTS OF OPERATIONS
Comparison of 12 and 40 weeks ended December 1, 2018 to 12 and 40 weeks ended December 2, 2017:
The following table and related discussion set forth certain information and comparisons regarding the components of our Condensed Consolidated Statements of Operations for the 12 and 40 weeks ended December 1, 2018 ("third quarter of fiscal 2018" and "first 40 weeks of fiscal 2018") and 12 and 40 weeks ended December 2, 2017 ("third quarter of fiscal 2017" and "first 40 weeks of fiscal 2017"). As of December 1, 2018 and December 2, 2017, we operated 2,277 and 2,323 stores, respectively.
 
12 weeks ended
 
December 1,
2018
 
% of Sales
 
December 2,
2017
 
% of Sales
Net sales and other revenue
$
13,840.4

 
100.0
 %
 
$
13,599.2

 
100.0
 %
Cost of sales
9,988.0

 
72.2
 %
 
9,974.6

 
73.3
 %
Gross profit
3,852.4

 
27.8
 %
 
3,624.6

 
26.7
 %
Selling and administrative expenses
3,678.0

 
26.6
 %
 
3,725.7

 
27.4
 %
Operating income (loss)
174.4

 
1.2